Although these studies strongly suggest the existence of a BC subtype-specific microbial composition, we are still far from defining a consensus microbial signature for HER2+ BCs because there is no agreement with regard to the bacterial taxa that are associated with the HER2+ subtype or their levels in the gut/BC tissue. This evidence concerns the gene ERBB2 and breast cancer.